Loading
Yanuki
ARTICLE DETAIL
RTX (Raytheon) Stock Surges to 12-Month High on Earnings, Upgrades, and Dividend Hike | RTX Raises 2025 Forecast on Strong Aerospace and Defense Demand | Vertex Pharmaceuticals Stock: Earnings and Revenue Analysis | Vertex Pharmaceuticals Q2 2025 Earnings: Revenue Jumps 12% | Defense Stocks: Analyzing LMT, RTX, and NOC for Investment Potential | Visa Stock Analysis: Early Dip and Long-Term Outlook | Aerospace and Defense Contractors Face Tariff and Supply Chain Challenges | RTX (Raytheon Technologies) Q1 2025 Earnings: Key Insights and Analysis | RTX (Raytheon) Stock Surges to 12-Month High on Earnings, Upgrades, and Dividend Hike | RTX Raises 2025 Forecast on Strong Aerospace and Defense Demand | Vertex Pharmaceuticals Stock: Earnings and Revenue Analysis | Vertex Pharmaceuticals Q2 2025 Earnings: Revenue Jumps 12% | Defense Stocks: Analyzing LMT, RTX, and NOC for Investment Potential | Visa Stock Analysis: Early Dip and Long-Term Outlook | Aerospace and Defense Contractors Face Tariff and Supply Chain Challenges | RTX (Raytheon Technologies) Q1 2025 Earnings: Key Insights and Analysis

Stock / Market Trends

RTX (Raytheon) Stock Surges to 12-Month High on Earnings, Upgrades, and Dividend Hike

RTX Co. (NYSE:RTX) is experiencing a surge in stock price, reaching a 12-month high. This rally is attributed to strong earnings, positive analyst ratings, and an increased dividend, overshadowing recent insider selling.

RTX Stock Hits 12-Month High on Strong Earnings, Analyst Upgrades, and Dividend Hike
Share
X LinkedIn

rtx stock
RTX (Raytheon) Stock Surges to 12-Month High on Earnings, Upgrades, and Dividend Hike Image via Daily Chhattisgarh News

Key Insights

  • RTX stock hit a 12-month high of $146.02, up 3.2%.
  • Analysts have upgraded RTX to "buy" or "overweight" ratings, with an average price target of $159.82.
  • The company reported EPS of $1.47 and revenue of $20.31 billion, exceeding expectations.
  • RTX increased its quarterly dividend from $0.63 to $0.68 per share.
  • Despite some insider selling, institutional investors hold 86.50% of the stock.

In-Depth Analysis

RTX's recent performance is driven by robust financial results and positive sentiment from Wall Street analysts. Several firms, including Benchmark and Morgan Stanley, have upgraded RTX stock. The company's earnings per share (EPS) of $1.47 and revenue of $20.31 billion surpassed analyst expectations. RTX also increased its quarterly dividend, signaling confidence in future cash flow. While there has been some insider selling, the market appears to be focused on the company’s strong operational performance and future prospects. RTX Corp ( RTX , Financial ) average brokerage recommendation is currently 2.2, indicating "Outperform" status. The average target implies an downside of 3.75% from the current price of $145.29. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at, suggesting a downside of 7.25% from the current price of $145.29.

Read source article

FAQ

Why is RTX stock performing well?

Strong earnings, analyst upgrades, and a dividend increase.

What is the analyst consensus on RTX?

The consensus is "Buy" with an average price target of $159.82.

Did RTX beat earnings estimates?

Yes, EPS was $1.47, and revenue was $20.31 billion, both exceeding estimates.

Has RTX increased its dividend?

Yes, the quarterly dividend increased to $0.68 per share.

Is there insider selling?

Yes, but institutional ownership remains high at 86.50%.

Takeaways

  • RTX stock is currently trading near its 12-month high.
  • Analysts are optimistic about RTX's future performance.
  • The company's strong financial results support the positive outlook.
  • Monitor RTX for potential investment opportunities, but be aware of potential downside according to GF Value estimates.

Discussion

Do you think RTX can maintain its current momentum? Share your thoughts in the comments below!

Share this article with others who need to stay ahead of this trend!

Sources

Disclaimer

This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.

All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.

This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.

Always do your own research (DYOR) before making any decisions based on the information presented.